Capecitabine in combination with oxaliplatin as first-line therapy for advanced gastric cancer: a case report

被引：1

作者：

Mazzola, Rosario ^{[1
]}

Alu, Massimiliano ^{[1
]}

Leonardi, Vita ^{[1
]}

Procopio, Giuseppe ^{[2
]}

Agostara, Biagio ^{[1
]}

机构：

[1] ARNAS Osped Civ, Dipartimento Oncol, Div Med Oncol, Palermo, Italy

[2] Fdn IRCCS Ist Nazl Tumori, Med Oncol Unit 2, Milan, Italy

来源：

TUMORI JOURNAL | 2011年 / 97卷 / 01期

关键词：

metastatic gastric cancer; XELOX; case report; first-line therapy; IN-SITU HYBRIDIZATION; GENE AMPLIFICATION; SUPPORTIVE CARE; CHEMOTHERAPY; CARCINOMA; HER-2; IMMUNOHISTOCHEMISTRY; OVEREXPRESSION; FLUOROURACIL; METHOTREXATE;

D O I：

10.1177/030089161109700120

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gastric cancer is one of the most common cancers worldwilde. The five-year survival for stage IV gastric cancer is around 5-10% in Western countries. Advanced gastric cancer is sensitive to numerous agents, but there is no generally accepted standard regimen. Here we report on a case of advanced gastric cancer occurring in a 72-year-old man who underwent treatment with capecitabine plus oxaliplatin, achieving a complete response. Free full text available at www.tumorionline.it

引用

页码：115 / 118

页数：4

共 27 条

[1]

[Anonymous], 2008, Cancer Facts Figures 2008

[2]

[Anonymous], 2009, J CLIN ONCOL S

[3] Gastric cancer in the era of molecularly targeted agents: current drug development strategies [J].

Arkenau, Hendrik-Tobias .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (07) :855-866

[4]

Bajetta E, 2009, TUMORI J, V95, P43

[5] Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients [J].

Barros-Silva, J. D. ;

Leitao, D. ;

Afonso, L. ;

Vieira, J. ;

Dinis-Ribeiro, M. ;

Fragoso, M. ;

Bento, M. J. ;

Santos, L. ;

Ferreira, P. ;

Rego, S. ;

Brandao, C. ;

Carneiro, F. ;

Lopes, C. ;

Schmitt, F. ;

Teixeira, M. R. .

BRITISH JOURNAL OF CANCER, 2009, 100 (03) :487-493

[6]

Burzykowski T, 2009, J CLIN ONCOL, V27

[7] The treatment of advanced gastric cancer:: current strategies and future perspectives [J].

Cervantes, A. ;

Rosello, S. ;

Roda, D. ;

Rodriguez-Braun, E. .

ANNALS OF ONCOLOGY, 2008, 19 :103-107

[8] Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].

Cunningham, David ;

Starling, Naureen ;

Rao, Sheela ;

Iveson, Timothy ;

Nicolson, Marianne ;

Coxon, Fareeda ;

Middleton, Gary ;

Daniel, Francis ;

Oates, Jacqueline ;

Norman, Andrew Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46

[9] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].

Cunningham, David ;

Allum, William H. ;

Stenning, Sally P. ;

Thompson, Jeremy N. ;

Van de Velde, Cornelis J. H. ;

Nicolson, Marianne ;

Scarffe, J. Howard ;

Lofts, Fiona J. ;

Falk, Stephen J. ;

Iveson, Timothy J. ;

Smith, David B. ;

Langley, Ruth E. ;

Verma, Monica ;

Weeden, Simon ;

Chua, Yu Jo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20

[10] Advances in the treatment of patients with gastric adenocarcinoma [J].

Foukakis, Theodoros ;

Lundell, Lars ;

Gubanski, Michael ;

Lind, Pehr A. .

ACTA ONCOLOGICA, 2007, 46 (03) :277-285

← 1 2 3 →